Skip to main content
Search
News, Views, and Advocacy From the Oncology Nursing Society
ONS Voice Home
  • News & Views
  • Advocacy
  • Stories
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
    • News & Views
    • Latest Articles
    • Clinical Practice
    • ONS News
    • ONS Leadership
    Trending Topics
    • Treatments
    • Research
    • Safety
    • COVID-19
    • Drug Reference Sheet
    • Clinical practice
    View All Topics
    Advocacy
    • Latest Articles
    • Updates
    • Get Involved
    Stories View All
    View All
    The Case of the Missing Oral Mucositis
    Radiation therapy
    The Case of the Missing Oral Mucositis
    October 22, 2021
    What It’s Like to Compete in the ONS Hackathon™
    Oncology nurse pride
    What It’s Like to Compete in the ONS Hackathon™
    September 17, 2021
    The Case of the Swift Sepsis Response
    Oncologic emergencies
    The Case of the Swift Sepsis Response
    September 03, 2021
    The Case of the GVHD Double-Take
    Treatment side effects
    The Case of the GVHD Double-Take
    August 24, 2021
    Nurses, Researchers Create Innovative Solutions to Ambulatory Care Challenges in ONS Hackathon
    Oncology nurse pride
    Nurses, Researchers Create Innovative Solutions to Ambulatory Care Challenges in ONS Hackathon
    August 06, 2021
    previous slide
    next slide
    Search
  • News & Views
  • Advocacy
  • Stories
    • Home

    Author Content

    Nursing Considerations for Lung Cancer Survivorship Care
    Survivorship care plans

    Nursing Considerations for Lung Cancer Survivorship Care

    As Americans reduce tobacco use and treatment and diagnosis advance, lung cancer survivorship rates are improving; however, it still remains the second most common type of cancer. The growing population needs appropriate survivorship care.

    August 05, 2021
    Nursing Considerations for Ovarian Cancer Survivorship Care
    Survivorship

    Nursing Considerations for Ovarian Cancer Survivorship Care

    Historically, ovarian cancer is often diagnosed at advanced stages because of vague symptoms and presentation, but with new advancements in diagnosis and treatment options, patients with the disease are living longer than ever.

    July 09, 2021
    Nursing Considerations for Head and Neck Cancer Survivorship Care
    Survivorship

    Nursing Considerations for Head and Neck Cancer Survivorship Care

    Despite accounting for only 3% of all cancer survivors, patients with head and neck cancers often require significant support and survivorship care. And oncology nurses can expect survivorship to grow with recent improvements in prognosis and treatment options, such as with reductions in human papillomavirus-related oropharyngeal cancers, which tend to affect young people and offer improved long-term survival rates.

    April 08, 2021
    Nursing Considerations for Colorectal Cancer Survivorship Care
    Survivorship care plans

    Nursing Considerations for Colorectal Cancer Survivorship Care

    As the third most common cancer among both men and women, colorectal cancer is a reality for the more than 1 million people in the United States who are living with or have a history of the disease. Advancements in early detection and treatment have improved outcomes, but many survivors experience late and long-term side effects that may vary in duration, intensity, and impact on their quality of life. Clinicians must tailor each survivorship care plan for a patient’s cancer type, stage, treatment received, psychosocial implications, and side effects or toxicities. Studies have shown that experiencing long-term side effects and symptoms can reduce survivors’ quality of life. 

    March 04, 2021
    Nursing Considerations for Breast Cancer Survivorship Care
    Breast cancer

    Nursing Considerations for Breast Cancer Survivorship Care

    More than 3.5 million people in the United States are living with a breast cancer diagnosis. Despite their large number, patients often report they do not receive appropriate follow-up care after completing treatment—and the situation is worsening, with pandemic-related delays in care affecting approximately half of breast cancer survivors.

    January 28, 2021
    Pancreatic Cancer Risk Factors, Diagnosis, Treatment, Side Effects, and Survivorship Considerations
    Pancreatic cancer

    Pancreatic Cancer Risk Factors, Diagnosis, Treatment, Side Effects, and Survivorship Considerations

    Pancreatic cancer is the ninth most common cancer in the United States, accounting for 3% of all cancers but causing 7% of cancer-related deaths, which equates to about 57,500 diagnoses and 47,050 deaths each year. The average person’s risk for pancreatic cancer is about 1 in 64.

    December 03, 2020
    Breast Cancer Prevention, Screening, Diagnosis, Treatment, Side Effect, and Survivorship Considerations
    Breast cancer

    Breast Cancer Prevention, Screening, Diagnosis, Treatment, Side Effect, and Survivorship Considerations

    In the United States, breast cancer is the most commonly diagnosed cancer in women. One in eight women will develop invasive disease in their lifetime with approximately 270,00 new cases diagnosed in the United States in 2019. Caucasian women have the highest incidence rate, whereas African American women are most likely to die from the disease. The five-year survival rate is 91%, with an estimated 3.8 million breast cancer survivors living in the United States.

    October 15, 2020
    Billing and Coding Breakdown Helps Nurses Recognize the Realities of Reimbursement
    Patient financial advocacy

    Billing and Coding Breakdown Helps Nurses Recognize the Realities of Reimbursement

    Understanding correct coding strategies is an important skill that affects billing and reimbursement for value-based cancer care. Meeting the requirements for complete and accurate documentation is critical to support healthcare claims. Both nurses and advanced practice providers have responsibilities in this work.

    September 30, 2020
    Glioblastoma Diagnosis, Treatment, Side Effect Management, and Survivorship Recommendations
    Treatment side effects

    Glioblastoma Diagnosis, Treatment, Side Effect Management, and Survivorship Recommendations

    Glioblastoma or glioblastoma multiform (GBM) is a primary central nervous system tumor. Approximately 23,890 new brain tumors are diagnosed in the United States each year, with GBM accounting for 38%. GBM can present as a primary diagnosis or evolve from a lower grade brain tumor.

    August 06, 2020
    Multiple Myeloma Prevention, Screening, Treatment, and Survivorship Recommendations
    Clinical practice

    Multiple Myeloma Prevention, Screening, Treatment, and Survivorship Recommendations

    Multiple myeloma is a plasma cell neoplasm and the second most common hematologic malignancy in the United States, although overall incidence rates are relatively low at approximately 32,000 annually. The overall five-year survival rate is 52%, and most people are diagnosed with the disease in later stages.

    June 09, 2020
    Oral and Oropharyngeal Cancer Prevention, Screening, Treatment, and Survivorship Recommendations
    Cancer screening

    Oral and Oropharyngeal Cancer Prevention, Screening, Treatment, and Survivorship Recommendations

    Approximately 53,000 cases of oral and oropharyngeal cancer are diagnosed in the United States each year. Men are twice as likely to develop the disease, and it typically affects people older than 55.  

    April 21, 2020
    Colorectal Cancer Prevention, Screening, Treatment, and Survivorship Recommendations
    Cancer screening

    Colorectal Cancer Prevention, Screening, Treatment, and Survivorship Recommendations

    Colorectal cancer (CRC) is the third most common cancer affecting men and women in the United States. When CRC is found at an early stage before it has spread, the five-year relative survival rate is about 90%, yet it remains a leading cause of cancer-related death among both genders. 

    March 17, 2020
    Telehealth Visits During COVID-19
    Clinical practice

    Telehealth Visits During COVID-19

    With the Centers for Disease Control and Prevention’s recommendations for practicing social distancing to slow the national risk of transmission of COVID-19 novel coronavirus, oncology nurses must take increased precautions with patients with cancer who are at increased risk for contracting or experiencing poorer outcomes from COVID-19. Patients require communication and education in these uncertain times.

    March 13, 2020
    Ovarian Cancer: Prevention, Screening, Treatment, and Survivorship Recommendations
    Ovarian cancer

    Ovarian Cancer: Prevention, Screening, Treatment, and Survivorship Recommendations

    Even though its incidence is less common, ovarian cancer is the fifth leading cause of death from cancer in women, according to the American Cancer Society. It also estimated more than 22,000 new cases of ovarian cancer in 2019, with a five-year survival of 47% for all stages.

    February 06, 2020
    Oncology Drug Reference Sheet: Entrectinib
    Treatments

    Oncology Drug Reference Sheet: Entrectinib

    Entrectinib was approved by the U.S. Food and Drug Administration in August 2019 as the third tumor-agnostic cancer drug, meaning it targets a specific mutation of the cancer, not the organ of origin. The other two currently approved tumor-agnostic drugs are larotrectinib and pembrolizumab.

    January 21, 2020
    Manage Cancer-Associated Anemia With Erythropoietin-Stimulating Agents
    Advanced practice nursing (APN)

    Manage Cancer-Associated Anemia With Erythropoietin-Stimulating Agents

    As a side effect of cancer or its treatment, anemia is associated with reduced quality of life, thanks to symptoms such as palpitations, fatigue, dyspnea, and dizziness. Etiology is often multifactorial with contributing factors such as suppression of hematopoiesis from malignancy or cancer treatments, bleeding, nutritional deficiencies, renal insufficiency, or hemolysis.

    October 31, 2019

    To discuss the information in this article with other oncology nurses, visit the ONS Communities.

    To report a content error, inaccuracy, or typo, email pubONSVoice@ons.org.

    Kathleen Sacharian MSN, CRNP
     
    Home
    News, Views, and Advocacy From the Oncology Nursing Society
  • Legal Notices
  • Contact Us
  • Conferences
  • Advertising
  • Newsroom
  • Sitemap

  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • ONS
  • Oncology Nursing Foundation
  • ONCC
    • © Copyright 2021 Oncology Nursing Society
     
    Back to Top ▲